These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35460077)

  • 1. Reply to: Comments on "Finding the optimal mammography screening strategy: A cost-effectiveness analysis of 920 modeled strategies".
    Kregting LM; Sankatsing VDV; Heijnsdijk EAM; de Koning HJ; van Ravesteyn NT
    Int J Cancer; 2022 Aug; 151(4):651-652. PubMed ID: 35460077
    [No Abstract]   [Full Text] [Related]  

  • 2. Comments on "Finding the optimal mammography screening strategy: A cost-effectiveness analysis of 920 modeled strategies".
    Braillon A
    Int J Cancer; 2022 Aug; 151(4):649-650. PubMed ID: 35460074
    [No Abstract]   [Full Text] [Related]  

  • 3. Incorporating Baseline Breast Density When Screening Women at Average Risk for Breast Cancer : A Cost-Effectiveness Analysis.
    Shih YT; Dong W; Xu Y; Etzioni R; Shen Y
    Ann Intern Med; 2021 May; 174(5):602-612. PubMed ID: 33556275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Finding the optimal mammography screening strategy: A cost-effectiveness analysis of 920 modelled strategies.
    Kregting LM; Sankatsing VDV; Heijnsdijk EAM; de Koning HJ; van Ravesteyn NT
    Int J Cancer; 2022 Jul; 151(2):287-296. PubMed ID: 35285018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the Cost-Effectiveness of Updated Breast Cancer Screening Guidelines for Average-Risk Women.
    Tina Shih YC; Dong W; Xu Y; Shen Y
    Value Health; 2019 Feb; 22(2):185-193. PubMed ID: 30711063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total cost-effectiveness of mammography screening strategies.
    Mittmann N; Stout NK; Lee P; Tosteson AN; Trentham-Dietz A; Alagoz O; Yaffe MJ
    Health Rep; 2015 Dec; 26(12):16-25. PubMed ID: 26676235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of abbreviated-protocol MRI screening for women with mammographically dense breasts in a national breast cancer screening program.
    Wang J; Greuter MJW; Vermeulen KM; Brokken FB; Dorrius MD; Lu W; de Bock GH
    Breast; 2022 Feb; 61():58-65. PubMed ID: 34915447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast MRI screening for average-risk women: A monte carlo simulation cost-benefit analysis.
    Mango VL; Goel A; Mema E; Kwak E; Ha R
    J Magn Reson Imaging; 2019 Jun; 49(7):e216-e221. PubMed ID: 30632645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reply to Opportunity cost of annual screening mammography.
    Arleo EK; Hendrick RE; Helvie MA; Sickles EA
    Cancer; 2018 Mar; 124(6):1298-1299. PubMed ID: 29266244
    [No Abstract]   [Full Text] [Related]  

  • 10. Mammography screening for breast cancer.
    Wiwanitkit V
    Maturitas; 2010 Aug; 66(4):435. PubMed ID: 20541879
    [No Abstract]   [Full Text] [Related]  

  • 11. The cost-effectiveness of digital breast tomosynthesis in a population breast cancer screening program.
    Wang J; Phi XA; Greuter MJW; Daszczuk AM; Feenstra TL; Pijnappel RM; Vermeulen KM; Buls N; Houssami N; Lu W; de Bock GH
    Eur Radiol; 2020 Oct; 30(10):5437-5445. PubMed ID: 32382844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Women aged 75 years and older benefit from mammography.
    Printz C
    Cancer; 2015 Jan; 121(2):165. PubMed ID: 25581117
    [No Abstract]   [Full Text] [Related]  

  • 13. Insights Into Breast Cancer Screening: A Computer Simulation of Two Contemporary Screening Strategies.
    Carter KJ; Castro F; Morcos RN
    AJR Am J Roentgenol; 2018 Mar; 210(3):564-571. PubMed ID: 29323554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-Effectiveness of Magnetic Resonance Imaging Screening for Women With Extremely Dense Breast Tissue.
    Geuzinge HA; Bakker MF; Heijnsdijk EAM; van Ravesteyn NT; Veldhuis WB; Pijnappel RM; de Lange SV; Emaus MJ; Mann RM; Monninkhof EM; de Koekkoek-Doll PK; van Gils CH; de Koning HJ;
    J Natl Cancer Inst; 2021 Nov; 113(11):1476-1483. PubMed ID: 34585249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness.
    Schousboe JT; Kerlikowske K; Loh A; Cummings SR
    Ann Intern Med; 2011 Jul; 155(1):10-20. PubMed ID: 21727289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overestimation of the Benefit-to-Harm Ratio of Risk-Based Mammography Screening in the United Kingdom-Reply.
    Pashayan N; Pharoah PDP
    JAMA Oncol; 2019 Mar; 5(3):428-429. PubMed ID: 30653219
    [No Abstract]   [Full Text] [Related]  

  • 17. Beyond the
    Destounis S
    AJR Am J Roentgenol; 2022 Sep; 219(3):525. PubMed ID: 35576520
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of specificity on cost-effectiveness of screening women at high risk of breast cancer with magnetic resonance imaging, mammography and ultrasound.
    Kaiser CG; Dietzel M; Vag T; Rübenthaler J; Froelich MF; Tollens F
    Eur J Radiol; 2021 Apr; 137():109576. PubMed ID: 33556759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland.
    de Gelder R; Bulliard JL; de Wolf C; Fracheboud J; Draisma G; Schopper D; de Koning HJ
    Eur J Cancer; 2009 Jan; 45(1):127-38. PubMed ID: 19038540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digital Breast Tomosynthesis Screening for Breast Cancer: It Is Cost-effective!
    Slanetz PJ
    Radiology; 2020 Oct; 297(1):49-50. PubMed ID: 32772875
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.